Rasagiline mesylate
NDC 71921-407, Rasagiline mesylate, tablet, from Florida Pharmaceutical Products, LLC.
- Product NDC
- 71921-407
- Status
- Listed
- Labeler
- Florida Pharmaceutical Products, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206153
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71921-407 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RASAGILINE MESYLATE.5 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71921-407-33 | 71921040733 | 30 TABLET in 1 BOTTLE (71921-407-33) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3b57a1c9-0ad9-40cf-a972-29851a658489NADAC price for package 71921040733
GET /v1/drugs/nadac/71921040733
Use it
Look up 71921-407 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71921-407 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71921-407. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.